Items where authors include "Archer, R."

Article

White, S., Zarotti, N., Beever, D. orcid.org/0000-0001-9063-3677 et al. (22 more authors) (2021) The nutritional management of people living with Amyotrophic Lateral Sclerosis (ALS): A national survey of dietitians. Journal of Human Nutrition and Dietetics, 34 (6). pp. 1064-1071. ISSN 0952-3871

Essat, M., Archer, R., Williams, I. et al. (10 more authors) (2020) Interventions to promote oral nutritional behaviours in people living with neurodegenerative disorders of the motor system : a systematic review. Clinical Nutrition, 39 (8). pp. 2547-2556. ISSN 0261-5614

Mshelia, S.E., Blackmore, C. orcid.org/0000-0001-6631-9602, Archer, R. et al. (1 more author) (2020) Factors affecting the successful implementation of Global Polio Eradication Initiative (GPEI) in low- and middle-income countries. Journal of Global Health, 10 (1). 010322. ISSN 2047-2978

Mshelia, S.E., Blackmore, C. orcid.org/0000-0001-6631-9602, Archer, R. et al. (1 more author) (2019) Factors influencing the implementation of Global Polio Eradication Initiative in low- and middle-income countries : a qualitative evidence synthesis. Journal of Global Health Reports, 3. e2019073.

Zarotti, N. orcid.org/0000-0002-8129-6151, Coates, E., McGeachan, A. et al. (22 more authors) (2019) Health care professionals’ views on psychological factors affecting nutritional behaviour in people with motor neuron disease : a thematic analysis. British Journal of Health Psychology, 24 (4). pp. 953-969. ISSN 1359-107X

Simpson, E.L. orcid.org/0000-0001-7353-5979, Ren, S. orcid.org/0000-0003-3568-7124, Hock, E.S. orcid.org/0000-0002-8617-8875 et al. (8 more authors) (2019) Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis. International Journal of Technology Assessment in Health Care, 35 (1). pp. 36-44. ISSN 0266-4623

Archer, R., Hock, E. orcid.org/0000-0002-8617-8875, Hamilton, J. orcid.org/0000-0003-3326-9842 et al. (6 more authors) (2018) Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews. Health Technology Assessment, 22 (66). pp. 1-294. ISSN 1366-5278

Bermejo, I. orcid.org/0000-0001-9105-8088, Stevenson, M., Archer, R. et al. (5 more authors) (2017) Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 35 (11). pp. 1141-1151. ISSN 1170-7690

Stevenson, M.D. orcid.org/0000-0002-3099-9877, Wailoo, A.J. orcid.org/0000-0002-9324-1617, Tosh, J.C. et al. (8 more authors) (2017) The cost-effectiveness of sequences of biological disease-modifying antirheumatic drug treatment in England for patients with rheumatoid arthritis who can tolerate methotrexate. Journal of Rheumatology, 44 (7). pp. 973-980. ISSN 0315-162X

Tappenden, P. orcid.org/0000-0001-6612-2332, Ren, S., Archer, R. et al. (6 more authors) (2016) A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy. PharmacoEconomics, 34 (10). pp. 1023-1038. ISSN 1170-7690

Williams, D.J., Archer, R., Archibald, P. et al. (46 more authors) (2016) Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015. Regenerative Medicine, 11 (5). pp. 483-492. ISSN 1746-0751

Campbell, A., Archer, R. and Ebbens, S. orcid.org/0000-0002-4727-4426 (2016) Preparation and 3D Tracking of Catalytic Swimming Devices. Journal of Visualized Experiments (113). e54247.

Archer, R., Tappenden, P., Ren, S. et al. (8 more authors) (2016) Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technoogyl Assessment, 20. 39. ISSN 1366-5278

Stevenson, M. orcid.org/0000-0002-3099-9877, Archer, R., Tosh, J. et al. (9 more authors) (2016) Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. Health Technology Assessment, 20 (35). pp. 1-610. ISSN 1366-5278

Essat, M., Tappenden, P., Ren, S. et al. (5 more authors) (2015) Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. ISSN 1170-7690

Archer, R., Paisley, S., Essat, M. et al. (2 more authors) (2015) Iterative sifting in the selection of research evidence: implications for reviews and other decision problems. International Journal of Technology Assessment in Health Care, 31 (1-2). 54 - 58. ISSN 0266-4623

Proceedings Paper

Williams, I., Norman, P., Essat, M. et al. (9 more authors) (2019) RNM-03 Factors associated with oral nutritional behaviours in people with motor neuron disease: a systematic review. In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 30th International Symposium on ALS/MND 2019, 04-06 Dec 2019, Perth, Australia. Taylor & Francis , p. 310.

Curley, R., Hoo, Z.H., Archer, R. et al. (1 more author) (2015) Is there a role for telemedicine in cystic fibrosis? A systematic review. In: THORAX. The Queen Elizabeth II Centre Broad Sanctuary, 2 to 4 December 2015, Westminster London. BMJ Publishing Group , A218-A219.